Market Overview

UPDATE: Morgan Stanley Raises PT to $55 on Verisk Analytics on Solid Q4, Healthcare Strength

Share:
Related VRSK
Earnings Scheduled For May 3, 2016
Verisk Analytics Announces Sale Of Healthcare Services Business For $820 Million
CreditRiskMonitor: A Cheap Micro-Cap With A Recession-Proof Business Model (Seeking Alpha)

Morgan Stanley maintained Verisk Analytics (NASDAQ: VRSK) with an Equal-weight rating and raised the price target from $47.00 to $55.00.

Morgan Stanley noted, "We view VRSK as one of the more stable, defensive analytics companies in our coverage. The company is the dominant provider of data and analytics to the Property Casualty Insurance industry, also servicing the mortgage, healthcare, and supply chain verticals. P&C trends are improving and we expect Healthcare to remain a key growth driver. … While we think Verisk has one of the best business models in our broader business services universe, this is reflected in the stock price."

Verisk Analytics closed at $53.90 on Tuesday.

Latest Ratings for VRSK

DateFirmActionFromTo
Mar 2016Sterne Agee CRTInitiates Coverage onNeutral
Dec 2015BarclaysMaintainsOverweight
Nov 2015Cantor FitzgeraldInitiates Coverage onBuy

View More Analyst Ratings for VRSK
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Price Target Analyst Ratings

 

Related Articles (VRSK)

View Comments and Join the Discussion!